Episode Summary
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area and what it’s like to be involved in lung cancer clinical trials. Alexandra’s story is inspiring. Diagnosed with lung cancer 8 years ago, her treatments have varied due to the discovery of a rare mutation called ALK and she is now involved in an innovative clinical trial using a targeted agent for patients with the ALK gene rearrangements. Alexandra is redefining survival rates for those with lung cancer and bringing new hope for patients all around the world.
Show Hosts
This episode’s host are:
- Mark Scott
- Alexandra Golledge, patient advocate, teletrials participant and lung cancer survivor
